New Zealand markets closed

Cano Health, Inc. (CANO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
8.87+0.53 (+6.35%)
At close: 04:00PM EDT
8.96 +0.09 (+1.01%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.14B
Enterprise value 3.20B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.32
Price/book (mrq)5.20
Enterprise value/revenue 1.34
Enterprise value/EBITDA 57.00

Trading information

Stock price history

Beta (5Y monthly) 1.56
52-week change 3-37.09%
S&P500 52-week change 3-16.88%
52-week high 314.32
52-week low 33.81
50-day moving average 36.17
200-day moving average 36.15

Share statistics

Avg vol (3-month) 34.47M
Avg vol (10-day) 38.2M
Shares outstanding 5241.57M
Implied shares outstanding 6N/A
Float 8173.2M
% held by insiders 131.95%
% held by institutions 173.48%
Shares short (30 Aug 2022) 420.81M
Short ratio (30 Aug 2022) 44.57
Short % of float (30 Aug 2022) 414.94%
Short % of shares outstanding (30 Aug 2022) 48.97%
Shares short (prior month 28 Jul 2022) 420.3M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin -1.14%
Operating margin (ttm)-4.48%

Management effectiveness

Return on assets (ttm)-3.51%
Return on equity (ttm)-9.13%

Income statement

Revenue (ttm)2.38B
Revenue per share (ttm)12.72
Quarterly revenue growth (yoy)100.60%
Gross profit (ttm)198.97M
EBITDA -32.23M
Net income avi to common (ttm)-27.25M
Diluted EPS (ttm)-0.67
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)47.85M
Total cash per share (mrq)0.21
Total debt (mrq)1.1B
Total debt/equity (mrq)131.27
Current ratio (mrq)2.02
Book value per share (mrq)1.91

Cash flow statement

Operating cash flow (ttm)-152.6M
Levered free cash flow (ttm)-80.19M